Purity: | 98% |
---|---|
Brand Name: | aierry |
Grade Standard: | Medicine Grade,veterinary grade |
Type: | peptide |
CAS No.: | 14636-12-5 |
Quick Details
Specifications
AIGP0043 Terlipressin Acetate
Molecular Formula:
C52H74N16O15S2
Relative Molecular Mass:
1227.39 g/mol
CAS-Number:
14636-12-5 (net)
Long-term Storage:
-20 ± 5°C
Sequence:
H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2acetate salt
(Disulfide bond)
Fields of Application:
Acute variceal hemorrhage (esophageal varices)
Hepatorenal syndrome
Norepinephrine-resistant septic shock - not yet an approved application
Active Substance:
Terlipressinis a synthetic analog of vasopressin and is used as a vasoactive drug in themanagement of hypotension.
Terlipressin represents a prodrug, it is converted to (Lys8)- vasopressin (LVP)after removal of the N-terminal triglycine in vivo. Terlipressin has a longerduration of action and a better safety profile than the parent compound
Molecular Formula:
C52H74N16O15S2
Relative Molecular Mass:
1227.39 g/mol
CAS-Number:
14636-12-5 (net)
Long-term Storage:
-20 ± 5°C
Sequence:
H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2acetate salt
(Disulfide bond)
Fields of Application:
Acute variceal hemorrhage (esophageal varices)
Hepatorenal syndrome
Norepinephrine-resistant septic shock - not yet an approved application
Active Substance:
Terlipressinis a synthetic analog of vasopressin and is used as a vasoactive drug in themanagement of hypotension.
Terlipressin represents a prodrug, it is converted to (Lys8)- vasopressin (LVP)after removal of the N-terminal triglycine in vivo. Terlipressin has a longerduration of action and a better safety profile than the parent compound